赛恩斯(688480) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥228,784,152.09, representing a year-on-year increase of 73.52%[2] - The net profit attributable to shareholders for Q3 2024 was ¥27,899,360.86, up 56.40% compared to the same period last year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was ¥26,575,425.16, an increase of 112.79% year-on-year[2] - Total operating revenue for the first three quarters of 2024 reached CNY 584,791,287.57, a significant increase of 46% compared to CNY 400,165,242.31 in the same period of 2023[16] - Net profit for the first three quarters of 2024 was CNY 147,298,144.59, representing a 153% increase from CNY 58,151,851.06 in 2023[17] - Earnings per share for the period was CNY 1.51, compared to CNY 0.57 in the previous year[18] Assets and Liabilities - The total assets at the end of Q3 2024 reached ¥1,752,356,416.60, reflecting a 17.37% increase from the end of the previous year[3] - The total assets of the company are reported at ¥1,752,356,416.60, up from ¥1,493,018,387.90[13] - The company's total liabilities increased to CNY 665,240,288.72, up from CNY 522,612,709.12 in the previous year, reflecting a growth of 27%[15] - The total equity attributable to shareholders reached CNY 1,044,388,712.50, an increase of 12% from CNY 931,793,098.82 in 2023[15] Cash Flow - The net cash flow from operating activities for the year-to-date period was -¥16,694,886.45, indicating a decrease in cash flow[2] - The cash inflow from investment activities was approximately $806.38 million in 2024, down from $1.09 billion in 2023, reflecting a decrease of about 26%[20] - The net cash flow from investment activities was negative at approximately -$345.14 million in 2024, compared to -$311.30 million in 2023[20] - The company's cash and cash equivalents at the end of Q3 2024 were approximately $163.07 million, down from $223.89 million at the end of Q3 2023, a decrease of about 27%[21] Research and Development - The company's R&D investment for Q3 2024 was ¥14,139,497.46, which is 52.15% higher than the same period last year[3] - Research and development expenses for the first three quarters were CNY 33,068,311.90, up from CNY 25,172,915.98 in the same period last year, indicating a 31% increase[16] - The company plans to continue increasing R&D investment and expanding its project pipeline[6] Shareholder Information - The total number of common shareholders at the end of the reporting period is 3,102[8] - The largest shareholder, Gao Weirong, holds 24,065,685 shares, representing 25.25% of the total shares[8] Investment and Acquisitions - The company completed the acquisition of its associate Fujian Zijinlong Chemical Co., Ltd. in February 2024, which contributed to increased investment income and profit growth[7] - The company reported investment income of CNY 62,307,837.53, a substantial rise from CNY 12,081,706.29 in the previous year[17] Operational Costs - Total operating costs for the same period were CNY 493,565,041.62, up 39% from CNY 353,865,446.54 in 2023[16] - Cash outflows for purchasing goods and services increased to approximately $393.33 million in 2024 from $203.30 million in 2023, marking an increase of about 93.5%[20] - The company’s cash outflows for employee compensation rose to approximately $124.90 million in 2024 from $84.74 million in 2023, an increase of about 47.3%[20] Accounting Standards - The company has not adopted new accounting standards for the current year, as indicated in the report[22]